Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Protein Expression and Purification
|
July 12, 2015
Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells
Shahid Rehan, Veli-Pekka Jaakola
Biochimica Et Biophysica Acta. Biomembranes
|
March 4, 2017
Functional reconstitution of human equilibrative nucleoside transporter-1 into styrene maleic acid co-polymer lipid particles
Shahid Rehan, Ville O Paavilainen, Veli-Pekka Jaakola
Biochemical Pharmacology
|
October 3, 2015
Thermodynamics and kinetics of inhibitor binding to human equilibrative nucleoside transporter subtype-1
Shahid Rehan, Yashwanth Ashok, Rahul Nanekar, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
September 11, 2019
Current Progress on Equilibrative Nucleoside Transporter Function and Inhibitor Design
Shahid Rehan, Saman Shahid, Tiina A Salminen, et al.
EMBO Reports
|
November 20, 2023
Molecular view of ER membrane remodeling by the Sec61/TRAP translocon
Sudeep Karki, Matti Javanainen, Shahid Rehan, et al.
Acta Biomaterialia
|
June 12, 2020
Pendant-bearing glucose-neopentyl glycol (P-GNG) amphiphiles for membrane protein manipulation: Importance of detergent pendant chain for protein stabilization
Hyoung Eun Bae, Cristina Cecchetti, Yang Du, et al.
Structure (London, England : 1993)
|
June 26, 2026
Cryo-EM structure of the Arabidopsisthaliana ribosome in translating and non-translating states
Sudeep Karki, Xun Lu, Anja O Paatero, et al.
Nature Chemistry
|
December 12, 2018
Rapamycin-inspired macrocycles with new target specificity
Zufeng Guo, Sam Y Hong, Jingxin Wang, et al.
Nature Chemical Biology
|
May 11, 2023
Signal peptide mimicry primes Sec61 for client-selective inhibition
Shahid Rehan, Dale Tranter, Phillip P Sharp, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 16, 2025
Preclinical characterization of novel multi-client inhibitors of Sec61 with broad antitumor activity
Eric Lowe, Janet L Anderl, David Bade, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Protein Expression and Purification
|
July 12, 2015
Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells
Shahid Rehan, Veli-Pekka Jaakola
Biochimica Et Biophysica Acta. Biomembranes
|
March 4, 2017
Functional reconstitution of human equilibrative nucleoside transporter-1 into styrene maleic acid co-polymer lipid particles
Shahid Rehan, Ville O Paavilainen, Veli-Pekka Jaakola
Biochemical Pharmacology
|
October 3, 2015
Thermodynamics and kinetics of inhibitor binding to human equilibrative nucleoside transporter subtype-1
Shahid Rehan, Yashwanth Ashok, Rahul Nanekar, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
September 11, 2019
Current Progress on Equilibrative Nucleoside Transporter Function and Inhibitor Design
Shahid Rehan, Saman Shahid, Tiina A Salminen, et al.
EMBO Reports
|
November 20, 2023
Molecular view of ER membrane remodeling by the Sec61/TRAP translocon
Sudeep Karki, Matti Javanainen, Shahid Rehan, et al.
Acta Biomaterialia
|
June 12, 2020
Pendant-bearing glucose-neopentyl glycol (P-GNG) amphiphiles for membrane protein manipulation: Importance of detergent pendant chain for protein stabilization
Hyoung Eun Bae, Cristina Cecchetti, Yang Du, et al.
Structure (London, England : 1993)
|
June 26, 2026
Cryo-EM structure of the Arabidopsisthaliana ribosome in translating and non-translating states
Sudeep Karki, Xun Lu, Anja O Paatero, et al.
Nature Chemistry
|
December 12, 2018
Rapamycin-inspired macrocycles with new target specificity
Zufeng Guo, Sam Y Hong, Jingxin Wang, et al.
Nature Chemical Biology
|
May 11, 2023
Signal peptide mimicry primes Sec61 for client-selective inhibition
Shahid Rehan, Dale Tranter, Phillip P Sharp, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 16, 2025
Preclinical characterization of novel multi-client inhibitors of Sec61 with broad antitumor activity
Eric Lowe, Janet L Anderl, David Bade, et al.
Page
of 1